產品詳情
簡單介紹：
Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Phospho-Insulin Receptor Beta (Tyr1355)
Cat. Number:
Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗體KL-3492R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The human insulin receptor is a heterotetrameric membrane glycoprotein consisting of disulfide linked subunits in a beta-alpha-alpha-beta configuration. The beta subunit (95 kDa) possesses a single transmembrane domain, whereas the alpha subunit (135 kDa) is completely extracellular. The insulin receptor exhibitsAnti-Phospho-Insulin Receptor Beta (Tyr1355)抗體 receptor tyrosine kinase (RTK) activity. RTKs are single pass transmembrane receptors that possess intrinsic cytoplasmic enzymatic activity, catalyzing the transfer of the gamma phosphate of ATP to tyrosine residues in protein substrates. RTKs are essential components of signal transduction pathways that affect cell proliferation, differentiation, migration and metabolism.
Included in this large protein family are the insulin receptor and the receptors for growth factors such as epidermal growth factor, fibroblast growth factor and vascular endothelial growth factor. Receptor activation occurs through ligand binding, which facilitates receptor dimerization and autophosphorylation of specific tyrosine residues in the cytoplasmic portion. The interaction of insulin with the alpha subunit of the insulin receptor activates the protein tyrosine kinase of the beta subunit, which then undergoes an autophosphorylation that increases its tyrosine kinase activity. Three adapter proteins, IRS1, IRS2 and Shc, become phosphorylated on tyrosine residues following insulin receptor activation. These three phosphorylated proteins then interact with SH2 domain containing signaling proteins.
Included in this large protein family are the insulin receptor and the receptors for growth factors such as epidermal growth factor, fibroblast growth factor and vascular endothelial growth factor. Receptor activation occurs through ligand binding, which facilitates receptor dimerization and autophosphorylation of specific tyrosine residues in the cytoplasmic portion. The interaction of insulin with the alpha subunit of the insulin receptor activates the protein tyrosine kinase of the beta subunit, which then undergoes an autophosphorylation that increases its tyrosine kinase activity. Three adapter proteins, IRS1, IRS2 and Shc, become phosphorylated on tyrosine residues following insulin receptor activation. These three phosphorylated proteins then interact with SH2 domain containing signaling proteins.
Also known as:
Insulin Receptor (phospho Y1355); Insulin Receptor (phospho Try1355); CD 220; CD220; CD220 antigen; HHF 5; HHF5; HIR B; INSR; Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗體INSR; Insulin receptor; Insulin receptor subunit beta; IR; INSR_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗體
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human.
●
Predicted Molecular Weight: 68kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Phospho-Insulin Receptor Beta (Tyr1355)抗體
Optimal working dilutions must be determined by the end user.
kl389Mu02 補體成分4a(C4a)多克隆抗體 Polyclonal Antibody to Complement Component 4a (C4a)
kl391Mu02 卵泡抑素(FS)多克隆抗體 Polyclonal Antibody to Follistatin (FS)
kl395Mu02 抑制素A(INHA)多克隆抗體 Polyclonal Antibody to Inhibin A (INHA)
kl396Mu02 性**結合球蛋白(SHBG)多克隆抗體 Polyclonal Antibody to Sex Hormone Binding Globulin (SHBG)
kl397Mu01 轉化生長因子β受體Ⅰ(TGFβR1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1)
kl397Mu02 轉化生長因子β受體Ⅰ(TGFβR1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Receptor I (TGFbR1)
kl399Mu02 高遷移率族蛋白1(HMG1)多克隆抗體 Polyclonal Antibody to High Mobility Group Protein 1 (HMG1)
kl402Mu02 基質金屬蛋白酶12(MMP12)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 12 (MMP12)
kl405Hu01 性別決定區Y框蛋白1(SOX1)多克隆抗體 Polyclonal Antibody to Sex Determining Region Y Box Protein 1 (SOX1)
kl413Mu02 粘蛋白1(MUC1)多克隆抗體 Polyclonal Antibody to Mucin 1 (MUC1)
kl416Mu02 早期生長應答因子1(EGR1)多克隆抗體 Polyclonal Antibody to Early Growth Response Protein 1 (EGR1)
kl417Hu01 鞘磷脂脂質蛋白1(PLP1)多克隆抗體 Polyclonal Antibody to Proteolipid Protein 1, Myelin (PLP1)
kl424Mu02 八聚體結合轉錄因子4(OCT4)多克隆抗體 Polyclonal Antibody to Octamer Binding Transcription Factor 4 (OCT4)
kl425Mu02 突觸素(SYP)多克隆抗體 Polyclonal Antibody to Synaptophysin (SYP)
kl431Mu02 顆粒酶M(GZMM)多克隆抗體 Polyclonal Antibody to Granzyme M (GZMM)
kl433Mu02 蛋白激酶Cδ(PKCδ)多克隆抗體 Polyclonal Antibody to Protein Kinase C Delta (PKCd)
kl437Mu02 雌**受體β(ERβ)多克隆抗體 Polyclonal Antibody to Estrogen Receptor Beta (ERb)
kl438Mu02 促生長**釋放**(GHRH)多克隆抗體 Polyclonal Antibody to Growth Hormone Releasing Hormone (GHRH)
kl439Mu02 蛋白激酶Cε(PKCε)多克隆抗體 Polyclonal Antibody to Protein Kinase C Epsilon (PKCe)
